𝔖 Bobbio Scriptorium
✦   LIBER   ✦

IL-3-Dependent Early Erythropoiesis Is Stimulated by Autocrine Transforming Growth Factor Beta

✍ Scribed by Ralph M. Böhmer

Book ID
111845931
Publisher
AlphaMed Press
Year
2004
Tongue
English
Weight
173 KB
Volume
22
Category
Article
ISSN
1066-5099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transforming growth factor beta stimulat
Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors
✍ Anne-Marie Heegaard; Zhongjian Xie; Marian Frances Young; Karina Lishmann Nielse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

## Abstract Biglycan is a small leucine‐rich proteoglycan which is localized in the extracellular matrix of bone and other specialized connective tissues. Both biglycan mRNA and protein are up‐regulated by transforming growth factor‐β~1~ (TGF‐β~1~) and biglycan appears to influence TGF‐β~1~ activit

Transforming growth factor-β1 is an auto
Transforming growth factor-β1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids
✍ Hélène Defacque; David Piquemal; Annie Basset; Jacques Marti; Thérèse Commes 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 1 views

Vitamin D and retinoids cooperate to inhibit the proliferation and induce the differentiation of human myelomonocytic U937 leukemia cells. In the present work, we investigated the role of TGF-␤ as an endogenous mediator of this process. We found that the TGF-␤1 precursor began to accumulate in cell

Enhancement by transforming growth facto
Enhancement by transforming growth factor-β 1 (TGF-β 1) of the proliferation of leukemic blast progenitors stimulated with IL-3
✍ Toshiya Suzuki; Masami Bessho; Kunitake Hirashima; Shuji Tohda; Kaoru Nagata; To 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 764 KB

## Abstract We studied the effect of transforming growth factor‐beta 1(TGF‐β 1) on colony formation of leukemic blast progenitors from ten acute myeloblastic leukemia (AML) patients stimulated with granulocyte colony‐stimulating factor (G‐CSF), granulocyte‐macrophage colony‐stimulating factor (GM‐C